The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Potential of tumor-informed ctDNA as an early predictive indicator for relapse in advanced ovarian cancer.
 
Christina Tauber
Research Funding - SAGA Diagnostics (Inst)
 
Fabian Trillsch
Honoraria - Abbvie; AstraZeneca; Eisai; MSD Oncology; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Eisai Germany; Immunogen; MSD Oncology; Tesaro/GSK
Research Funding - AstraZeneca (Inst); SAGA Diagnostics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Immunogen; Tesaro/GSK
 
Magdalena Postl
Research Funding - SAGA Diagnostics (Inst)
 
Valentina Glueck
No Relationships to Disclose
 
Mira Gliga
No Relationships to Disclose
 
Nuria Segui
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
 
Karen Howarth
Employment - NeoGenomics Laboratories; SAGA Diagnostics
Stock and Other Ownership Interests - NeoGenomics Laboratories; SAGA Diagnostics
 
Cecilia Forsberg
Employment - SAGA Dx
Stock and Other Ownership Interests - SAGA Dx
 
Miguel Alcaide Torres
Employment - SAGA DIAGNOSTICS
Stock and Other Ownership Interests - SAGA DIAGNOSTICS
Patents, Royalties, Other Intellectual Property - Methods for ctDNA monitoring
 
Lucia Oton
Employment - SAGA Dx
Stock and Other Ownership Interests - SAGA Dx
 
Yilun Chen
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
Patents, Royalties, Other Intellectual Property - 63/497,872 63/650,048 63/650,061 63/402,511 63/402,512
 
Lao Saal
Stock and Other Ownership Interests - SAGA Diagnostics US, Inc.
Honoraria - AstraZeneca
Consulting or Advisory Role - DoMore Diagnostics AS
Patents, Royalties, Other Intellectual Property - Patent filed for methods related to ultrasensitive quantification of nucleotide sequence variants.
 
Gerda Hofstetter
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Mirjana Kessler
No Relationships to Disclose
 
Christoph Grimm
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Eisai Europe; GlaxoSmithKline; MSD Oncology; Sandoz
Speakers' Bureau - Abbvie/Genentech; AstraZeneca; Eisai Europe; GlaxoSmithKline; Merck; Sandoz
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; GlaxoSmithKline; Merck